Harton is a biotechnology platform that develops personalized immune therapies through scalable cell manufacturing processes, targeting the unique immune profiles of individual patients. This approach addresses the limitations of traditional one-size-fits-all treatments by providing tailored therapies that enhance patient outcomes in healthcare.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional "one-size-fits-all" cell therapies may not be effective for all patients due to the unique immune profiles of individuals. Scalable manufacturing processes for personalized cell therapies are needed to address the limitations of current treatment approaches.
Solution
Harton is developing a biotechnology platform focused on personalized immune therapies by creating scalable cell manufacturing processes. This approach aims to tailor treatments to the specific immune characteristics of each patient. By customizing therapies, Harton seeks to improve patient outcomes compared to standard, non-personalized treatments. The platform is designed to efficiently produce these individualized therapies, making them more accessible.
Target Audience
The primary target audience includes healthcare providers and patients seeking personalized immune therapies.
Features
- Scalable cell manufacturing processes for personalized therapies
- Platform designed to target individual patient immune profiles
- Focus on enhancing patient outcomes through tailored treatments